-- title: "Feline Upper Respiratory Infection Complex: Differential Diagnosis and Molecular Testing" category: "molecular" metaDescription: "A comprehensive reference on the differential diagnosis and molecular testing of feline upper respiratory infection complex, including PCR panels for FHV-1, FCV, Chlamydia felis, and Bordetella bronchiseptica, sample collection techniques, and interpretation of co-infections." primaryKeyword: "feline upper respiratory infection complex" secondaryKeywords: ["FHV-1", "FCV", "Chlamydia felis", "Bordetella bronchiseptica", "multiplex qPCR", "conjunctival swab", "co-infection", "differential diagnosis"]

Feline Upper Respiratory Infection Complex: Differential Diagnosis and Molecular Testing

Introduction

Feline upper respiratory infection (URI) complex represents a multifactorial disease syndrome with viral, bacterial, and fungal etiologies. The primary pathogens include feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), Chlamydia felis, and Bordetella bronchiseptica. Additional agents such as Mycoplasma species, Cryptococcus species, and coronaviruses may contribute to or mimic URI signs [1, 8, 10]. The clinical overlap among these pathogens necessitates precise molecular diagnostics to guide appropriate therapy, implement biosecurity measures, and monitor antimicrobial resistance patterns. This article provides an exhaustive review of differential diagnostic considerations and molecular testing strategies for feline URI complex, with emphasis on polymerase chain reaction (PCR) panel design, sample collection optimization, and interpretation of co-infections.

Differential Diagnosis of Feline URI

The differential diagnosis for feline URI must account for infectious, neoplastic, inflammatory, and structural conditions. Table 1 summarizes the key infectious agents and their distinguishing features.

Table 1. Differential Diagnosis of Infectious Causes of Feline Upper Respiratory Disease

Non-infectious differentials include nasopharyngeal polyps, foreign bodies, neoplasia (lymphoma, adenocarcinoma), allergic rhinitis, and oronasal fistulae. Fungal causes such as Cryptococcus neoformans complex should be considered in endemic regions or when granulomatous lesions are present [1, 12]. Emerging pathogens, including certain coronavirus variants and highly pathogenic avian influenza strains, may also present with respiratory signs in felines and warrant ongoing surveillance [4, 5, 6, 7].

Sample Collection and Handling for Molecular Testing

Optimal sample collection is critical for the sensitivity of molecular assays. For feline URI complex, the recommended specimens include:

• Conjunctival swabs: preferred for detection of FHV-1, Chlamydia felis, and Mycoplasma species. Swabs should be rolled over the conjunctival sac to collect epithelial cells, as these pathogens are cell-associated.
• Oropharyngeal swabs: optimal for FCV detection, as the virus replicates in the oral mucosa and tonsillar tissue.
• Nasal swabs: may be used for Bordetella and Mycoplasma detection but are less standardized than conjunctival samples.
• Bronchoalveolar lavage or transtracheal wash: indicated when lower respiratory involvement is suspected.

Swabs should be placed in viral transport medium (e.g., 2 mL of sterile phosphate-buffered saline with 2% fetal bovine serum and antibiotics). Refrigeration at 2-8 degrees Celsius is acceptable for up to 48 hours. For long-term storage or shipment, freezing at -70 degrees Celsius or lower is recommended. The use of flocked nylon swabs increases cell recovery compared to traditional cotton swabs.

Molecular Testing: PCR Panel Design and Assay Physics

Real-time PCR (qPCR) and reverse transcription qPCR (RT-qPCR) are the gold standard molecular methods for feline URI complex diagnostics. These assays rely on the amplification of specific nucleic acid targets using fluorogenic probes (TaqMan or hydrolysis probes). The physics involves thermal cycling: denaturation at 94-96 degrees Celsius, annealing at 50-65 degrees Celsius (depending on primer melting temperatures), and extension at 72 degrees Celsius. Fluorescence is measured at the end of each cycle, and quantification cycles (Cq) correlate with initial target copy number.

Multiplex qPCR panels allow simultaneous detection of multiple pathogens in a single reaction. Thieulent and colleagues developed a multiplex one-step qPCR/RT-qPCR assay for simultaneous detection of SARS-CoV-2 and pathogens associated with feline respiratory disease complex, demonstrating high analytical sensitivity and specificity [13]. Such panels typically target:

• FHV-1: thymidine kinase (TK) gene or glycoprotein B (gB) gene.
• FCV: RNA-dependent RNA polymerase (RdRp) gene or capsid gene.
• Chlamydia felis: ompA gene or 16S rRNA gene.
• Bordetella bronchiseptica: fhaB gene or fla gene.
• Internal control: often a housekeeping gene (e.g., feline glyceraldehyde-3-phosphate dehydrogenase, GAPDH) or an exogenous synthetic RNA to monitor extraction and amplification efficiency.

The analytical sensitivity of qPCR for FHV-1 is typically 10-100 copies per reaction, and for FCV 1-10 copies per reaction [13]. The inclusion of an internal control is essential to rule out PCR inhibition, particularly when sampling from mucoid or exudative specimens.

Interpretation of Co-Infections

Co-infections are frequently observed in feline URI complex, particularly in multi-cat households, shelters, and catteries. Epidemiological studies have reported co-infection rates exceeding 30% in symptomatic cats [8, 10]. The most common co-infections involve FHV-1 with Chlamydia felis or FCV with Bordetella bronchiseptica. The clinical significance of co-infections remains debated. Some studies suggest synergistic effects with increased severity of conjunctivitis and rhinitis, while others find no difference in clinical scores compared to mono-infections.

Interpretation of PCR results requires integration of clinical signs, vaccination history, and patient age. For example, FHV-1 DNA can be detected in latently infected cats without active disease, especially following stress or corticosteroid administration. A positive FHV-1 PCR from a conjunctival swab in a cat with acute onset of conjunctivitis is highly suggestive of active infection. Conversely, low-level detection of FCV in a vaccinated cat may represent vaccine strain shedding (modified-live vaccines), which can persist for up to three weeks post-vaccination.

Quantitative PCR offers additional interpretive power: high viral loads (low Cq values) correlate with active replication and clinical disease. Serial testing can distinguish active infection from low-level shedding or contamination.

Workflow for Molecular Diagnosis of Feline URI

The following Mermaid decision tree outlines a diagnostic workflow for feline URI complex, incorporating clinical evaluation, sample collection, and molecular testing.

flowchart TD
    A[Cat presents with sneezing, conjunctivitis, nasal discharge], > B{Clinical history & physical exam}
    B, > C[Oropharyngeal ulcers present?]
    C, >|Yes| D[Suspect FCV]
    C, >|No| E[Conjunctivitis predominant?]
    E, >|Yes| F[Consider FHV-1, Chlamydia felis]
    E, >|No| G[Cough or nasal discharge?]
    G, >|Yes| H[Consider Bordetella, Mycoplasma]
    G, >|No| I[Consider fungal, neoplastic, or other causes]
    D, > J[Collect oropharyngeal and conjunctival swabs for multiplex PCR]
    F, > J
    H, > J
    I, > K[Consider additional diagnostics: cytology, imaging, antigen testing]
    J, > L[Multiplex qPCR panel: FHV-1, FCV, C. felis, B. bronchiseptica, + internal control]
    L, > M{Results}
    M, >|Single pathogen detected| N[Targeted therapy based on agent]
    M, >|Multiple pathogens detected| O[Assess relative Cq values, clinical severity]
    O, > P[Prioritize treatment for high-load pathogens]
    M, >|All negative but clinical signs persistent| Q[Repeat testing with extended panel: Mycoplasma, Cryptococcus, Mycobacterium]
    Q, > R[Consider non-infectious differentials]

Advanced Considerations in Molecular Testing

Recent advances in feline URI molecular diagnostics include the development of multiplex panels incorporating emerging pathogens. Ju and colleagues performed spectrum detection and analysis of infectious pathogens in the feline respiratory tract, identifying a broader range of agents including coronaviruses and influenza viruses [10]. The emergence of highly pathogenic avian influenza H5N1 in mammals has prompted inclusion of influenza A virus targets in some feline respiratory panels [5, 7]. Additionally, the feline model for SARS-CoV-2 has provided insights into neutrophil dynamics and immune responses relevant to viral respiratory disease [4, 9]. Understanding host-pathogen interactions at the molecular level, such as the cross-presentation of coronavirus peptides by feline MHC class I, informs diagnostic target selection [6].

The differentiation of vaccine virus from field virus remains a challenge for FCV and FHV-1. Sequencing of the FCV capsid gene or FHV-1 glycoprotein genes may be required for epidemiological investigations. The evolution of FCV into virulent systemic strains further complicates interpretation [11].

For bacterial pathogens, the detection of antimicrobial resistance genes via multiplex PCR is increasingly integrated into respiratory panels. Surveillance of Bordetella bronchiseptica and Mycoplasma species for resistance markers (e.g., tet, erm, aad) supports antimicrobial stewardship.

References

1. Dzimira S. Feline Cryptococcosis: Two Case Reports and a Literature Review. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41901732/

2. Mitra N, Jadhao A, Dhende AV, et al. First report of fatal feline pulmonary tuberculosis caused by the emerging zoonotic pathogen Mycobacterium orygis in a cat from India. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41712109/

3. Luo D, Xie W, Li N, et al. Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40503218/

4. Gunasekara S, Shatnawi S, More S, et al. Comparative analysis of neutrophil dynamics and disease in SARS-CoV-2 Delta and Omicron variants utilizing an in vivo feline model for COVID-19. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40475786/

5. Mena A, von Fricken ME, Anderson BD. The Impact of Highly Pathogenic Avian Influenza H5N1 in the United States: A Scoping Review of Past Detections and Present Outbreaks. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40143238/

6. Qiao P, Yue C, Peng W, et al. Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2. J Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40073263/

7. Brüssow H. The Arrival of Highly Pathogenic Avian Influenza Viruses in North America, Ensuing Epizootics in Poultry and Dairy Farms and Difficulties in Scientific Naming. Microb Biotechnol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39641589/

8. Umar S, Muhammad S, Mouzahim M, et al. Burden of Common Respiratory Pathogens Among Cats in China. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39575527/

9. Gunasekara S, Tamil Selvan M, Murphy CL, et al. Characterization of Neutrophil Functional Responses to SARS-CoV-2 Infection in a Translational Feline Model for COVID-19. Int J Mol Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39337543/

10. Ju H, Yang D, Jin J, et al. Spectrum detection and analysis of the epidemiological characteristics of infectious pathogens in the feline respiratory tract. Arch Virol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39147982/

11. Wei Y, Zeng Q, Gou H, et al. Update on feline calicivirus: viral evolution, pathogenesis, epidemiology, prevention and control. Front Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38756726/

12. Teh A, Pritchard E, Donahoe SL, et al. A case of disseminated cryptococcosis with abdominal involvement due to Cryptococcus neoformans species complex in a Ragdoll cat and false-negative cryptococcal antigen lateral flow tests due to the postzone phenomenon. Aust Vet J. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38567673/

13. Thieulent CJ, Carossino M, Peak L, et al. Development and validation of multiplex one-step qPCR/RT-qPCR assays for simultaneous detection of SARS-CoV-2 and pathogens associated with feline respiratory disease complex. PLoS One. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38517847/

14. Lee HK, Walls G, Anderson G, et al. Prolonged Bacteroides pyogenes infection in a patient with multiple lung abscesses. Respirol Case Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38455503/

15. Wang F, Yang G, Yan L. Crystal Structures of Fusion Cores from CCoV-HuPn-2018 and SADS-CoV. Viruses. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38400047/